Discover the detailed record of transactions filed by Parsey Merdad, Directeur Médical. Director active across 4 companies, notably Gilead Sciences INC. In total, 36 disclosures have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €2.2m. Activity tracked since 15 August 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Parsey Merdad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Parsey Merdad is Directeur Médical and also serves as Chief Medical Officer at Gilead Sciences, INC. and Gilead Sciences INC, and as Director at Ardelyx, INC. and Sagimet Biosciences Inc. The declarant has 36 filings in total, and across the sampled recent filings, sales total EUR 2,242,294, with a date range from 2021-08-24 to 2026-06-18 and a modal transaction nature of Option exercise.